Combination Therapies and Doxorubicin's Evolving Role
Doxorubicin rarely works alone. It's typically part of combination regimens—paired with other chemotherapies, targeted agents, or immunotherapies—to improve outcomes and reduce resistance. As oncology evolves toward precision medicine, doxorubicin's role is being refined, and combination strategies are shaping its continued use in the doxorubicin market. In the Doxorubicin Market,...
0 Σχόλια 0 Μοιράστηκε 102 Views 0 Προεπισκόπηση